On Jun. 25, 2020, SIGA Technologies announced the deliveries of oral TPOXX (tecovirimat) to the U.S. Department of Health and Human Services (HHS) for prevention of smallpox.

These deliveries, valued at approximately $32 million, are the initial deliveries of the contract option exercises announced in Apr. 2020. SIGA’s full 19C BARDA Contract has up to approximately $414 million of procurement-related options remaining for future exercise.